QMS Medical Allied Services Complete Financial Statements

QMSMEDI • Review detailed financials to uncover trends, confirm thesis & journal trades
3 Years of Data
2025 - 2023

Complete Financial Data Export

Export complete financial statements for QMS Medical Allied Services (QMSMEDI). Downloads include all available records across all periods. For market performance, see the QMSMEDI stock price today .

Profitability Ratios

Net Profit Margin 8.89% 2025 data
EBITDA Margin 15.56% 2025 data
Operating Margin 15.00% 2025 data
Return on Assets 2.11% 2025 data
Return on Equity 3.74% 2025 data

Balance Sheet Ratios

Current Ratio 12.00 2025 data
Debt to Equity 1.78 2025 data
Equity Ratio 56.32% 2025 data
Asset Turnover 0.24 2025 data

Year-over-Year Growth Analysis

Comparing Sept 2024 vs Sept 2025
Revenue Growth
+18.4%
Year-over-Year
EBITDA Growth
-12.5%
Year-over-Year
Expense Growth
+26.7%
Year-over-Year
Assets Growth
+40.7%
Year-over-Year
Equity Growth
+35.4%
Year-over-Year
Liabilities Growth
+40.7%
Year-over-Year
Operating Cash Flow Growth
+1900.0%
Year-over-Year
Investing Cash Flow Growth
-1433.3%
Year-over-Year

Income Statement

Periods ₹ Crores
Particulars Sept 2025 Mar 2025 Jun 2025 Sept 2024 Mar 2024 Jun 2024 Dec 2024 Dec 2023
Revenue 45 46 47 38 32 31 44 35
Expenses 38 38 40 30 28 26 37 30
EBITDA 7 8 7 8 4 5 7 5
Operating Profit Margin % 15.00% 14.00% 14.00% 19.00% 12.00% 16.00% 16.00% 14.00%
Depreciation 1 1 1 1 1 1 1 1
Interest 1 1 1 1 1 1 1 1
Profit Before Tax 5 5 5 6 2 3 5 3
Tax 1 1 1 1 1 1 2 1
Net Profit 4 4 3 4 2 2 4 2
Earnings Per Share (₹) 1.71 1.87 1.64 1.93 0.86 1.34 1.63 1.37

Balance Sheet

Years Annual Data ₹ Crores
Particulars 2025 2024
ASSETS
Total Assets 190 135
Current Assets 120 106
Fixed Assets 53 24
Capital Work in Progress 3 2
Investments 3 2
Other Assets 131 108
LIABILITIES
Total Liabilities 190 135
Current Liabilities 10 3
Non-Current Liabilities
SHAREHOLDERS' EQUITY
Total Equity 107 79
Share Capital 18 18
Reserves & Surplus 72 61

Cash Flow Statement

Periods ₹ Crores
Particulars March 2025 March 2024
Operating Activities 20 1
Investing Activities -46 -3
Financing Activities 26 0
Net Cash Flow 1 -1